Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.

@article{Buttery2011ReductionIR,
  title={Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.},
  author={Jim P. Buttery and Stephen Bernard Lambert and Keith Grimwood and Michael D. Nissen and Emma J Field and Kristine Macartney and Jonathan D. Akikusa and Julian J Kelly and Carl D Kirkwood},
  journal={The Pediatric infectious disease journal},
  year={2011},
  volume={30 1 Suppl},
  pages={S25-9}
}
INTRODUCTION : Rotavirus vaccines were introduced into the funded Australian National Immunization Program (NIP) in July 2007. Due to purchasing arrangements, individual states and territories chose either a 2-dose RV1 (Rotarix, GSK) regimen or 3-dose RV5 (Rotateq, Merck/CSL) regimen. This allowed comparison of both vaccines in similar populations with high infant vaccination coverage. METHODS : Admission and rotavirus identification data from the major pediatric hospitals in 3 states (2… CONTINUE READING